Full-Time

Associate Director

Commercial Data Management

Posted on 2/20/2025

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Compensation Overview

$209k - $231kAnnually

Senior, Expert

San Bruno, CA, USA

Ability to work onsite in South San Francisco at least 3 days a week.

Category
Data Management
Data & Analytics
Required Skills
SQL
Tableau
Data Analysis

You match the following Cytokinetics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor's degree in computer science, data science, or a related field is required
  • 7+ years of biotech or pharma experience in IT, analytics, and/or data management
  • Expertise with standard pharmaceutical data sources (such as Rx, HCP/HCO demographics, formulary, CRM, CLM, etc.) required
  • Experience with MDM concepts and platforms and SQL-based data warehouse design
  • Experience with Tableau, Alteryx, and/or other BI tools
  • Knowledge of data management capabilities (data governance, data quality, metadata management, master data management, data lifecycle management, and data lineage)
  • Experience in product launch and/or establishing new data environments
  • Shown success in directing and managing multiple external vendors
  • Excellent project management skills, including the ability to lead in an environment with multiple partners and contending priorities
  • Good interpersonal and communication skills, including the ability to translate business requirements into technical requirements and the ability to communicate complex technology concepts to commercial partners and end-users in a manner that ties to their business objectives
  • Proven commitment to excellence and continuous improvement
  • Ability to work cross-functionally in a team-based environment, including external vendors while fostering a culture that is reflective of Cytokinetics’ values
  • Ability to plan, coordinate, and complete multiple projects efficiently, on time, and within budget in an environment of challenging and changing priorities
  • Business travel, by air or car, is required for internal and external business meetings
  • Ability to work onsite in South San Francisco at least 3 days a week
  • Compliance with all laws, regulations, policies, and procedures that govern the conduct of Cytokinetics activities
Responsibilities
  • Lead with curiosity, plan, and execute commercial data and analytics initiatives in close collaboration with IT and commercial stakeholders
  • Maintain a Commercial Data Map, recording the location and use of each data source used by the Commercial team
  • Manage and provide direction to the vendor managing the Commercial Data Warehouse, Master Data Management (MDM), and data and analytics ecosystem
  • Establish and manage BI technical processes to ensure that reports and dashboards are produced on schedule
  • Lead data onboarding and data warehouse enhancement projects, including integration of CRM data
  • Working with the analytics team and supporting vendors, create and manage the roadmap for enhancements to our data architecture and analytics capabilities
  • Responsible for planning, budgeting, contracting, and accrual activities related to the Commercial Data and Analytics environments and initiatives
  • Taking initiative and partnering with Commercial Analytics and Field Operations, lead and improve Cytokinetics’ data and data management ecosystem
  • Brings critical thinking, and organized skills with an emphasis on a business partner-centric mindset
  • Executes initiatives and follows up with stakeholders to ensure project or operational activities are scheduled and completed on time
  • Together with vendor partners, enable data stewardship that meets business needs
  • Identify, evaluate, and maintain relationships with best-in-class vendors
  • Develop, implement, and manage processes, in partnership with the Commercial department, that follow all applicable laws (e.g., HIPAA) and Cytokinetics’ policies
  • Know the latest data and analytics techniques and capabilities, leading the implementation of new capabilities and standard methodologies
Desired Qualifications
  • Master’s degree is preferred
  • Experience with Veeva CRM, Network and OpenData are preferred
  • Experience with Azure capabilities and any certifications

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Size

501-1,000

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent investments indicate strong interest in muscle activators and inhibitors.
  • Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
  • Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

What critics are saying

  • Increased competition could impact market share and profitability.
  • Potential delays in clinical trials could hinder drug commercialization.
  • Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company has a robust pipeline including omecamtiv mecarbil and aficamten.
  • Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-5%

2 year growth

-2%
Stock Titan
Jan 6th, 2025
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) - Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 9:00 AM Pacific Time in the Borgia Room of the Westin St. Francis Hotel in San Francisco, CA.

BioSpace
Dec 20th, 2024
Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China

Cytokinetics announces Sanofi acquired rights to develop and commercialize Aficamten in Greater China.

MarketBeat
Nov 26th, 2024
Intech Investment Management LLC Invests $1.73 Million in Cytokinetics, Incorporated (NASDAQ:CYTK)

Intech Investment Management LLC invests $1.73 million in Cytokinetics, Incorporated (NASDAQ:CYTK).

MediaPost
Oct 11th, 2024
Cytokinetics Educates Docs On Non-Physical Ordeals Of Cardio Condition

Setting the stage for its first consumer product after 25 years as a biopharma development company, Cytokinetics has launched "HCM Beyond the Heart," an awareness campaign educating cardiologists and other healthcare professionals (HCP) about the personal burdens caused by hypertrophic cardiomyopathy (HCM), a leading cause of sudden cardiac death.

Business Directory 88
Aug 21st, 2024
Armistice Capital Performance: A Closer Look at Healthcare Investment Strategies

Armistice Capital has invested in Cytokinetics Incorporated, a late-stage biopharmaceutical organization investigating treatments for impaired muscle function-related cardiovascular and neuromuscular diseases.